Image

Prospective Evaluation of Topical Almond Oil vs Hydroquinone

Prospective Evaluation of Topical Almond Oil vs Hydroquinone

Recruiting
18 years and older
Female
Phase 4

Powered by AI

Overview

The purpose of this study is to analyze facial pigmentation and skin microbiome changes after topical almond oil application, compared to the use of topical hydroquinone.

Description

The purpose of this experiment is to analyze facial pigmentation and skin microbiome changes after topical almond oil application, compared to the use of topical hydroquinone.

There will be a total of 50 subjects:

  • 25 randomized to receive almond oil nightly
  • 25 randomized to receive 2% hydroquinone nightly

Study Timelines:

  • The duration of an individual subject's participation will last from the day of the consent/screening (visit 1) until visit 5 where they will have images taken and measurements collected to assess skin pigment, skin hydration, sebum excretion rate.
  • The duration of participation is 4 months.
  • The estimated time for the investigators to complete primary analysis is 2 years.

Eligibility

Inclusion Criteria:

  • Premenopausal women of Fitzpatrick skin types 3 to 6

Exclusion Criteria:

  • Those with a nut allergy
  • Smoking is an independent risk factor and serves as a confounder for the development of facial aging [18]. Therefore current smokers, those that have smoked within the past year, and former smokers with greater than a 20 pack year history of smoking will be excluded.
  • Those with an autoimmune photosensitive condition or a known genetic condition with a deficiency in collagen production (such as Ehlers-Danlos syndrome) will be excluded as this can be a confounder for facial photoaging.
  • Hormonal medications or therapies will not be allowed unless they have been stable on their medications for at least 2 months. Examples include oral contraceptives, progesterone-based injections, and estrogen based hormonal replacement therapy.
  • Those who have undergone any cosmetic procedures to the face in the 4 months prior to enrollment in the opinion of the investigator. People that have undergone deeper chemical peels (TCA based peels) within 1 year prior to enrollment will also not be eligible.
  • Individuals who are unwilling to discontinue vitamin E containing supplements and food sources during the washout and intervention.
  • Individual who are unwilling to discontinue topical cosmetic products during the duration of the study.
  • Individuals who are not willing to engage in a two-week washout on topical treatments known to affect facial pigmentation and these agents will be restricted during the study period as well. These include topicals that contain:
    • Retinoids such as tretinoin, adapalene, retinol.
    • Antioxidant ingredients such as vitamin C or vitamin E.
    • Pigment-reducing agents such as hydroquinone, azelaic acid, kojic acid per the discretion of the investigator except for the hydroquinone that is provided in this study.
    • Topicals that contain a nut oil or nut extract as part of their ingredient list.
  • Furthermore, subjects will be asked to refrain from use of any other topical

    products for one week prior to each visit apart from the study agents supplied from this study.

Study details
    Skin Pigmentation

NCT04875715

University of California, Davis

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.